PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
- PMID: 20600548
- DOI: 10.1016/j.tox.2010.06.007
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
Abstract
Generic PBPK models, applicable to a large number of substances, coupled to parameter databases and QSAR modules, are now available for predictive modelling of inter-individual variability in the absorption, distribution, metabolism and excretion of environmental chemicals. When needed, Markov chain Monte Carlo methods and multilevel population models can be jointly used for a Bayesian calibration of a PBPK model, to improve our understanding of the determinants of population heterogeneity and differential susceptibility. This article reviews those developments and illustrates them with recent applications to environmentally relevant questions.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
QSARs for PBPK modelling of environmental contaminants.SAR QSAR Environ Res. 2011 Mar;22(1-2):129-69. doi: 10.1080/1062936X.2010.548351. SAR QSAR Environ Res. 2011. PMID: 21391145
-
Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.Regul Toxicol Pharmacol. 2006 Jun;45(1):44-54. doi: 10.1016/j.yrtph.2005.12.007. Epub 2006 Jan 25. Regul Toxicol Pharmacol. 2006. PMID: 16442684
-
Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.Risk Anal. 2006 Aug;26(4):925-43. doi: 10.1111/j.1539-6924.2006.00789.x. Risk Anal. 2006. PMID: 16948686
-
Physiologically based modelling and prediction of drug interactions.Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):154-61. doi: 10.1111/j.1742-7843.2009.00488.x. Epub 2009 Nov 11. Basic Clin Pharmacol Toxicol. 2010. PMID: 19912164 Review.
-
Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(1):31-53. doi: 10.1081/GNC-200051856. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005. PMID: 16291521 Review.
Cited by
-
Addressing human variability in next-generation human health risk assessments of environmental chemicals.Environ Health Perspect. 2013 Jan;121(1):23-31. doi: 10.1289/ehp.1205687. Epub 2012 Oct 19. Environ Health Perspect. 2013. PMID: 23086705 Free PMC article.
-
A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk.Front Pharmacol. 2013 Jan 22;3:204. doi: 10.3389/fphar.2012.00204. eCollection 2012. Front Pharmacol. 2013. PMID: 23346056 Free PMC article.
-
Translational learning from clinical studies predicts drug pharmacokinetics across patient populations.NPJ Syst Biol Appl. 2017 Mar 28;3:11. doi: 10.1038/s41540-017-0012-5. eCollection 2017. NPJ Syst Biol Appl. 2017. PMID: 28649438 Free PMC article.
-
Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors.Environ Health Perspect. 2024 Mar;132(3):37005. doi: 10.1289/EHP11891. Epub 2024 Mar 18. Environ Health Perspect. 2024. PMID: 38498338 Free PMC article.
-
Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.Nanomaterials (Basel). 2020 Jun 29;10(7):1267. doi: 10.3390/nano10071267. Nanomaterials (Basel). 2020. PMID: 32610468 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources